Connor, Clark & Lunn Investment Management (CC&L)’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.44M	Sell	1,835,424 -155,503	-8%	-$637K	0.01%	612
2025 Q4	$6.71M	Sell	1,990,927 -170,891	-8%	-$444K	0.02%	568
2025 Q3	$2.83M	Sell	2,161,818 -45,130	-2%	-$46.7K	0.01%	747
2025 Q2	$1.58M	Buy	2,206,948 +718,904	+48%	+$564K	0.01%	926
2025 Q1	$2.19M	Buy	1,488,044 +1,146,589	+336%	+$2.73M	0.01%	706
2024 Q4	$1.51M	Buy	341,455 +215,166	+170%	+$873K	0.01%	804
2024 Q3	$520K	Buy	126,289 +75,917	+151%	+$408K	﹤0.01%	1088
2024 Q2	$328K	Buy	+50,372	New	+$356K	﹤0.01%	1160
2024 Q1	–	Sell	-303,675	Closed	-$3.47M	–	1612
2023 Q4	$3.47M	Sell	303,675 -197,006	-39%	-$1.95M	0.02%	525
2023 Q3	$4.82M	Sell	500,681 -136	-0%	-$1.33K	0.03%	409
2023 Q2	$5.33M	Buy	500,817 +8,293	+2%	+$89.1K	0.03%	385
2023 Q1	$5.18M	Buy	492,524 +189,959	+63%	+$2.13M	0.03%	361
2022 Q4	$3.75M	Buy	+302,565	New	+$3.43M	0.02%	415
2019 Q4	–	Sell	-59,175	Closed	-$508K	–	1011
2019 Q3	$508K	Buy	+59,175	New	+$575K	﹤0.01%	677
2016 Q1	–	Sell	-48,238	Closed	-$468K	–	870
2015 Q4	$468K	Buy	48,238 +1,433	+3%	+$13.8K	﹤0.01%	553
2015 Q3	$408K	Buy	+46,805	New	+$437K	﹤0.01%	556